TOPVISN
0332 S0.165 ↓
0.165 ↓
-0.005 (-2.9%)| High | 0.165 |
| Low | 0.165 |
| Open | 0.165 |
| Volume | 13,000 |
| Volume (B/S) | 167,000 / 2,100 |
| Price Bid/Ask | 0.165 / 0.170 |
| 52w | 0.160 - 0.265 |
| ROE | -1.99 |
| P/E | -55.56 |
| EPS | -0.30 |
| DPS | 1.00 |
| DY | 6.06% |
| NTA | 0.1504 |
| P/B | 1.10 |
| RPS | 14.64 |
| PSR | 1.13 |
| Market Cap | 51.1M |
| Shares (mil) | 309.82 |
| RQoQ |
| CAGR |
3Y
63.7%
TTM
-116.3%
5Y
17.1%
TTM
133.3%
|
|
| RSI(14) | Neutral 41.6 |
| Stochastic(14) | Neutral 33.3 |
| Stochastic RSI(14) | Oversold 0.0 |
| Average Volume (3M) | 210,200 |
| Relative Volume | 0.2 |
| Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
|---|---|---|---|---|---|---|
| 31 Dec, 2025 | 33,819 | 1,707 | 0.5500 | 1.82 | ||
| 31 Dec, 2024 | 22,258 | -1,868 | -0.5500 | -1.82 | View |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 Nov 2025 | 31 Dec 2025 | Interim Dividend | 10 Dec 2025 | 31 Dec 2025 | 0.0100 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 Dec, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 Feb 2025 | 31 Dec 2024 | Final Dividend | 26 Jun 2025 | 21 Jul 2025 | 0.0100 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
A vision for growth
In the healthcare sector, attention typically centres on the heavyweights, namely the private hospitals and pharmaceutical groups. Yet, smaller players in the eye care segment are quietly gaining ground.TheStar -
Metro Healthcare focusing on maternity healthcare expansion
METRO Healthcare Bhd (KL:METRO), which runs a chain of in vitro fertilisation (IVF) centres in the country, is focusing on its expansion in the maternity healthcare business, as it looks to cement its position as a leading women’s healthcare provider. “Since our listing on the LEAP Mark...TheEdge -
Topvision catat pertumbuhan stabil, fokus pengembangan pasaran
KUALA LUMPUR: Topvision Eye Specialist Bhd (Topvision), penyedia perkhidmatan perubatan penjagaan mata terkemuka di Malaysia, mencatatkan pertumbuhan hasil stabil sebanyak RM11.54 juta bagi suku keempat tahun kewangan 2024 (S4 TK2024), meningkat 1.85 peratus daripada RM11.33 juta pada tempoh sama tahun sebelumnya.BeritaHarian -
IPOs - Malaysia’s IPO market reaches new high in nearly two decades, leads Southeast Asia
MALAYSIA’s number of initial public offerings (IPOs) reached its highest level in 2024 since 2005, leading regionally in terms of the number of deals. In 2005, Malaysia’s IPO count stood at 79. This resurgence was largely driven by the listings of 99 Speed Mart Retail Holdings Bhd (KL:9...TheEdge -
马股2024年IPO表现特优 3只股比首发价溢价逾200%
(吉隆坡30日讯)今年马股的首发股总数和筹资总额冠绝东南亚。一年共迎来55只首发股,远超全年的42只首发股目标,不仅比去年的32家大增72%,更创下19年来新高!这批首发股当中,多达35只股的股价表现优于首发价,表现十分亮眼。马股今年在主要板和创业板各别迎来了11只和35只新股,而且有35只新股股价至今都优于首发价,而低于首发价的新股则有8只,同时有4只股在“领先企业家加速平台”(LEAP)登场。在创业板挂牌的新上市公司似乎表现最佳,因为上市至今,股价涨幅最高的新股大多是来自创业板。截至1...Chinapress
Recent Announcements
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATUK LIEW HOCK NEAN
-
Changes in Director's Interest (Section 219 of CA 2016) - DATUK LIEW HOCK NEAN
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM ANGELA LOO VOON PEI
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATUK LIEW HOCK NEAN
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM ANGELA LOO VOON PEI